Took 5 months from approval to first patient imaged, so not exactly light speed. Anyone know what proportion of nuclear machines have a combined CT in the USA, the spect overcomes a big disadvantage of V/q as you get a non contrast CT anyway so gives you clues like a negative CTPA if there is other pathology causing the presentation for the investigation besides a PE.
Then potentially technical installation is tied to an upgrade in the imaging hardware. Should get there and higher and more streamlined reimbursement should help adoption, but 5 is a bit few and wouldn't be covering costs
Ann: Cyclopharm Business Update, page-4
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
-0.015(1.06%) |
Mkt cap ! $155.5M | |||
| Open | High | Low | Value | Volume |
| $1.42 | $1.42 | $1.40 | $57.92K | 41.32K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8677 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.41 | 1640 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| CYC (ASX) Chart |